Determination of celecoxib in human plasma by liquid chromatography-tandem mass spectrometry
Language English Country Netherlands Media print-electronic
Document type Evaluation Study, Journal Article
PubMed
22633154
DOI
10.1016/j.jchromb.2012.05.013
PII: S1570-0232(12)00285-1
Knihovny.cz E-resources
- MeSH
- Celecoxib MeSH
- Adult MeSH
- Spectrometry, Mass, Electrospray Ionization methods MeSH
- Cyclooxygenase 2 Inhibitors blood MeSH
- Plasma chemistry MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Pyrazoles blood MeSH
- Sulfonamides blood MeSH
- Tandem Mass Spectrometry methods MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Names of Substances
- Celecoxib MeSH
- Cyclooxygenase 2 Inhibitors MeSH
- Pyrazoles MeSH
- Sulfonamides MeSH
A liquid chromatography-electrospray tandem mass spectrometry method was developed and validated to quantitate celecoxib in human plasma. The assay was based on protein precipitation with methanol and liquid chromatography on a C₁₈ column (55 mm × 2 mm, 3 μm), the mobile phase consisted of methanol-10 mM ammonium acetate (75:25, v/v). Quantification was performed by mass spectrometry in the multiple reaction monitoring mode with negative electrospray ionization at m/z 380→316 and 384→320 for celecoxib and the internal standard celecoxib-D₄, respectively. The lower limit of quantitation was 7.0 ng/ml using 0.1 ml of plasma and linearity was demonstrated up to 1800 ng/ml. Intra-assay and inter-assay precision expressed by relative standard deviation was less than 4% and inaccuracy did not exceed 6% at all levels. The assay was applied to the analysis of samples from a pharmacokinetic study.
References provided by Crossref.org